2020 - 09 - 03
A.MENARINI DIAGNOSTICS and BIOACTIVA DIAGNOSTICA GMBH SIGN AN EXCLUSIVE AGREEMENT FOR LIOFERON® TB/LTBI, A TEST TO DIAGNOSE LATENT TUBERCULOSIS INFECTION
2020 - 09 - 01
ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR® POC instrument.
2020 - 07 - 24
A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing
2020 - 07 - 16
Menarini Diagnostics announces Technology Transfer Agreement to develop its own COVID 19 RT PCR assay
2020 - 04 - 15
Menarini dona 17.000 test de diagnóstico rápido frente a la COVID-19
2020 - 04 - 01
Credo Diagnostics Biomedical And A. Menarini Diagnostics Sign An Exclusive Distribution Agreement For Sars-cov-2 Assay On The Vitapcrtm Platform
2020 - 02 - 01
MEDLAB Middle East